Marshall E. Kadin, MD

Professor, Dermatology

Marshall Kadin
401.456.2000

Biography

Dr. Marshall Kadin is a current Professor of Dermatology at the Boston University School of Medicine. His current research involves investigating the role of cytokines in the pathogenesis of cutaneous T cell lymphomas.

Other Positions

  • Roger Williams Medical Center

Education

  • Northwestern University, MD
  • Northwestern University, BA

Publications

  • Published on 2/21/2019

    Hanson SE, Hassid VJ, Branch-Brooks C, Liu J, Kadin ME, Miranda R, Butler CE, Clemens MW. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2019 Feb 21. PMID: 30789639.

    Read at: PubMed
  • Published on 1/31/2019

    Kadin ME. What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Aesthet Surg J. 2019 Jan 31; 39(Supplement_1):S28-S35. PMID: 30715174.

    Read at: PubMed
  • Published on 4/22/2018

    Kadin ME, Morgan J, Xu H, Epstein AL, Sieber D, Hubbard BA, Adams WP, Bacchi CE, Goes JCS, Clemens MW, Medeiros LJ, Miranda RN. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis. Hum Pathol. 2018 08; 78:54-62. PMID: 29689246.

    Read at: PubMed
  • Published on 3/3/2018

    Sun J, Yi S, Qiu L, Fu W, Wang A, Liu F, Wang L, Wang T, Chen H, Wang L, Kadin ME, Tu P, Wang Y. SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile. J Invest Dermatol. 2018 08; 138(8):1795-1804. PMID: 29510190.

    Read at: PubMed
  • Published on 12/15/2017

    Yi S, Sun J, Qiu L, Fu W, Wang A, Liu X, Yang Y, Kadin ME, Tu P, Wang Y. Dual Role of EZH2 in Cutaneous Anaplastic Large Cell Lymphoma: Promoting Tumor Cell Survival and Regulating Tumor Microenvironment. J Invest Dermatol. 2018 05; 138(5):1126-1136. PMID: 29248547.

    Read at: PubMed
  • Published on 9/1/2017

    Kadin ME, Glicksman CA. Commentary on: Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman. Aesthet Surg J. 2017 09 01; 37(8):NP88-NP89. PMID: 29036946.

    Read at: PubMed
  • Published on 7/1/2017

    Kadin ME, Morgan J, Xu H, Glicksman CA. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2017 07 01; 37(7):771-775. PMID: 28402493.

    Read at: PubMed
  • Published on 6/5/2017

    Perera LP, Zhang M, Nakagawa M, Petrus MN, Maeda M, Kadin ME, Waldmann TA, Perera PY. Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies. Am J Hematol. 2017 Sep; 92(9):892-901. PMID: 28543380.

    Read at: PubMed
  • Published on 5/5/2017

    Fan P, Nong L, Sun J, Liu X, Kadin ME, Li T, Tu P, Wang Y. Primary cutaneous anaplastic large cell lymphoma with intralymphatic involvement associated with chronic lymphedema. J Cutan Pathol. 2017 Jul; 44(7):616-619. PMID: 28337783.

    Read at: PubMed
  • Published on 4/18/2017

    Wang X, Dasari S, Nowakowski GS, Lazaridis KN, Wieben ED, Kadin ME, Feldman AL, Boddicker RL. Retinoic acid receptor alpha drives cell cycle progression and is associated with increased sensitivity to retinoids in T-cell lymphoma. Oncotarget. 2017 Apr 18; 8(16):26245-26255. PMID: 28412739.

    Read at: PubMed

View 262 more publications: View full profile at BUMC

View all profiles